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 
Abstract—In this paper magnetic resonance imaging (MRI) is 
investigated for monitoring the penetration of high intensity 
focused ultrasound (HIFU) in vitro and in vivo rabbit brain. A 
single element spherically focused transducer of 5 cm diameter, 
focusing at 10 cm and operating at 2 MHz was used. A 
prototype MRI- compatible positioning device is described. 
MRI images were taken using fast spin echo (FSE). The length 
of the lesions in vivo rabbit brain was much higher than the 
length in vitro, proving that the penetration in the in vitro brain 
is limited by reflection due to trapped bubbles in the blood 
vessels.  
 
I.  INTRODUCTION 
hermal ablation of brain in animals with high intensity 
focused ultrasound (HIFU) was very popular in the 50’s 
and 60’s [1-2]. HIFU was used in the clinical setting by 
Fry and Johnson [3] and showed that HIFU had the potential 
to treat brain cancer. Several groups used hyperthermia 
(heating of several minutes at 43 oC) to treat brain tumours 
[4-5]. Such clinical trials were abandoned probably due to 
the inexistence of effective imaging modalities to guide the 
therapy. Especially for the case of brain it is extremely 
important to have absolute control of the ablation in order to 
avoid vital brain tissue damage such as the neurons. Now 
with the advancement of HIFU technology guided by 
magnetic resonance imaging (MRI), it will be possible to 
conduct clinical studies for brain cancer. 
Since 1994 several studies by the group of Dr. Hynynen 
[6-11] demonstrated the creation of lesions in animal brain 
using MRI for monitoring. However, in these studies only 
pure thermal lesions were shown. Also in the above studies 
the production of well-controlled large lesions was never 
demonstrated. In this paper we have explored extensively the 
use of MRI to image both lesions created under thermal and 
cavitation or boiling mechanisms. Also in this paper we 
demonstrate the creation of well controlled large thermal and 
bubbly lesions. Another issue that was never demonstrated in 
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previous studies is the lesion penetration deep in tissue, an 
issue which is also explored in this paper for in vitro and in 
vivo exposures. 
Currently there is a HIFU system which is guided by MRI 
developed by Insightech which treads fibroids [12]. This 
system which is already FDA approved has been deployed in 
30 locations worldwide. Therefore, HIFU guided by MRI, 
opens the possibility for treating tumors in other organs. 
A single element spherically focused transducer of 5 cm 
diameter, focusing at 10 cm and operating at 2 MHz was 
used. The transducer was scanned in a 3-d grid using an MRI 
compatible mechanical positioning device. The positioning 
device designed is simple, cost effective, portable and 
universal. By universal we mean that it can be used in any 
MRI scanner available, since it is placed on the table of the 
MRI scanner and therefore integration with all MRI scanners 
is possible. Also the current device includes a flexible 
coupling system, and thus it can be used in all the anatomies 
accessible by HIFU (liver, kidney, breast, brain and 
pancreas). For both in vitro and in vivo experiments we have 
used New Zealand rabbits. 
In this paper the goal was to investigate the effectiveness 
of MRI to monitor therapeutic protocols of HIFU in the 
brain. For such investigation, we have used the basic pulse 
sequences T1-w and T2-w fast spin echo (FSE). These MRI 
pulse sequences have been successful in other organs 
regarding their ability to identify thermal lesions. For 
example in muscle the contrast of lesions was investigated by 
Hynynen et al. [13], in kidney by Hynynen et al. [14], and 
Damianou et al. [15], in liver by Rowland et al. [16], and in 
prostate by Rouviere et al. [17], and by Pisani et al. [18].  
 
II. MATERIALS AND METHODS 
A. HIFU/MRI SYSTEM 
Fig. 1 shows the block diagram of the HIFU/MRI system 
which includes the following subsystems: 1) HIFU system, 
2) MR imaging, 3). Positioning device (robot) and associate 
drivers. A brief description of each of the subsystems flows 
below. 
1). HIFU system: The HIFU system consists of a signal 
generator (HP 33120A, Agilent technologies, Englewood, 
CO, USA), a RF amplifier (250 W, AR, Souderton, PA, 
USA), and a spherically shaped bowl transducer made from 
piezoelectric ceramic of low magnetic susceptibility (Etalon, 
Lebanon, IN, USA). The transducer operates at 2 MHz, has 
focal length of 10 cm and diameter of 5 cm. The transducer  
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Fig. 1. HIFU system under MRI guidance showing the various 
functionalities of the HIFU/MRI system. 
 
is rigidly mounted on the MRI-compatible positioning 
system (MEDSONIC LTD, Limassol, Cyprus). 
2). MRI Imaging: The 3-d positioning device and the 
transducer were placed inside a MRI scanner (Signa 1.5 T, 
by General Electric, Fairfield, CT, USA). A spinal coil (USA 
instruments, Cleveland, OH, USA) was used. 
3). Positioning device:  
3.1). Description of the mechanical design: The robot has 
been developed initially for three degrees-of-freedom, but it 
can be easily developed for 5 degrees of motion.  Since the 
positioning device is placed on the table of the MRI scanner 
its height should be around 55 cm (bore diameter of the MRI 
scanner). The length of the positioning device is 45 cm and 
its width 30 cm. The weight of the positioning device is only 
6 kg and therefore it can be considered as portable. 
Fig. 2.A shows the rectangular base of the positioning 
device made out of polyethylene. This plastic base holds the 3 
stages that establish motion in the X, Y and Z direction. Four 
polyethylene angles are placed on the base. Two brass rods are 
attached to the 4 angles. A fixed polycarbonate pulley is 
supported on polyethylene angles through a plastic rod. A 
piezoelectric motor (USR60-S3N, Shinsei Kogyo Corp., 
Tokyo, Japan) is fixed on another polyethylene angle. A 
neoprene belt is placed around the fixed pulley and the pulley 
which is coupled to the motor. This figure shows also the water 
container that host the transducer. The transducer is immersed 
in the water container which is filled with degassed water or 
saline. The water is poured in a mylar bag. The mylar bag is 
made thin enough to conform to the contours of the target. A 
circular window is opened in the water container in order to 
allow ultrasound energy to be applied through the body. For 
the purpose of brain ablation, the head of the subject is placed 
inside an open MRI coil. 
Fig. 2.B shows the bottom side of the polyethylene sheet 
that establishes motion in the X-direction. If the motor is 
energized, the belt which is coupled to this sheet will rotate, 
and eventually linear motion of this sheet is established. This 
sheet is coupled to the brass rods of the base (Fig. 2.A). 
Fig. 2.C shows the rectangular sheet (top side) which is used 
to provide motion in the Y-axis. The same principles as in Fig. 
2.A are implemented. The only difference is the smaller size of 
this sheet. Fig. 2.D shows the bottom side of the polyethylene 
sheet that establishes motion in the Y-direction. 
Fig. 2.E shows the angle that carries the Z-stage. This angle 
is placed on the stage shown in Fig. 2.D. Fig. 2.F shows the 
rectangular sheet made out of polyethylene for moving the 
transducer in the Z axis (same principles are applied as in Fig. 
2.A). Fig. 2.G shows the bottom side of the polyethylene sheet 
that establishes motion in the Z-direction. 
Fig. 2.H shows the holder of the transducer. A plastic rod is 
attached on the Z –axis sheet. A brass rod is coupled to the 
plastic rod. The transducer holder is attached to the brass rod. 
The HIFU transducer is coupled to the holder. More details of 
this positioning device can be found in [19]. 
 
Fig. 2 Schematic of the robot showing all of its stages. 
3.2). Robot drivers: 
The box hosting the motor drivers is placed outside the MRI 
room since magnetic materials are involved. Fig. 3 shows the 
wiring diagram of the driving electronics and computer-
controlled interface.  A DC supply (24 V, 6 A) is used to 
drive the Shinsei drivers. Wires from the Shinsei drivers are 
connected to a PCI 6602 interface card (National 
instruments, Austin, Texas, USA) via a connecting block. 
The PCI 6602 interface card includes timing and digital I/O 
modules. The interface is connected in a PC (Dell Inc. 
Round Rock, Texas, USA).  
The motors are driven when the ground and clockwise 
terminals of the Shinsei drivers are connected (clockwise 
rotation) or when the ground and anti-clockwise terminals of 
the Shinsei drivers are connected (anti -clockwise rotation). 
This is achieved by initiating a command from the software 
which places two digital output terminals of the PCI card 
(for example ground and clockwise) in the same potential. 
Movement of a certain axis can be achieved also manually 
by means of an ON-OFF-ON switch. 
 
B. In vitro experiments 
Various in vitro experiments were carried out using MRI 
to image the lesions created in brain tissue using HIFU.  
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Fig. 3 the wiring diagram of the driving electronics and computer-
controlled interface 
 
The acoustical coupling depicted in Fig. 4.A was used for the 
in vitro experiments. In this method the tissue is placed 
outside the water container which is filled with degassed 
water. Due to the weight of the water container the coupling 
when using this method is excellent. This method can be 
described as a superior to inferior approach, meaning that the 
transducer is on top of the tissue. In the commercial system 
described by Stewart et al. [12] the approach used is inferior 
to superior, meaning that the transducer in below the tissue. 
Totally 4 rabbit brains were ablated. 
 
C. In vivo experiments 
In Fig. 4.B the approach used for acoustical coupling is 
lateral meaning that ultrasound propagates to the tissue either 
from left or right. This method is used to couple ultrasound 
to the rabbit brain in vivo. The tissue with this method has to 
be in good contact with the water container in order to 
achieve good coupling. 
For the in vivo experiments, New Zealand adult rabbits 
were used weighting approximately 3.5-4 kg. Three rabbits 
were used in the experiments. The rabbits were anaesthetized 
using a mixture of 500 mg of ketamine (100 mg/mL, Aveco, 
Ford Dodge, IA), 160 mg of xylazine (20 mg/mL, Loyd 
Laboratories, Shenandoah, IA), and 20 mg of acepromazine 
(10 mg/mL, Aveco, Ford Dodge, IA) at a dose of 1 mL/kg.  
The presence of the skull in the ultrasonic path not only 
distorts the field by reflection, but may also destroy the 
underlying tissue in contact with it by absorbing ultrasonic 
energy and dissipating it as heat. Therefore, a craniotomy 
was necessary in order to permit unimpeded passage of the 
cone of sound. The extent of the craniotomy depends on the 
solid angle of radiation and the depth of the target from the 
cranial surface. The larger the angle and the deeper the 
target, the larger the size of craniotomy needed. For the 
transducer used and a target depth of 1 cm, a circular 
craniotomy of 3 cm in diameter was adequate. The animal 
experiments protocol was approved by the national body in 
Cyprus responsible for animal studies (Ministry of 
Agriculture, Animal Services). 
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Fig. 4 Coupling method for A) in vitro experiments and B) in vivo 
experiments. 
 
D. HIFU parameters 
The in situ spatial average intensity was estimated based on 
the applied power and the half-power width of the beam of 
the transducer. The details of the intensity estimation can be 
found in [21]. In all the exposure, unless stated otherwise the 
ultrasound was turn on continuously for 20 s.  
 
E. MRI processing 
The following parameters were used for T1-W FSE: TR=500 
ms, TE=9 ms, slice thickness=3 mm (gap 0.3 mm), 
matrix=256x256, FOV=16 cm, NEX=1, and ETL=8. For 
T2-W FSE: TR=2500 ms, TE=60 ms, slice thickness=3 mm 
(gap 0.3 mm), matrix=256x256, FOV=16 cm, NEX=1, and 
ETL=8. The Region of Interest (ROI) was circular with 
diameter of nearly 2 mm. 
 
III. RESULTS 
 
Fig. 5 shows MRI images using T1-w FSE of a lesion 
deep in the brain (in vitro). The length of the lesions is 
smaller than expected possibly due to the reflection caused 
by the trapped bubbles. Fig. 6 shows the lesion deep in brain 
in vivo and demonstrates that good penetration of HIFU in 
brain can be achieved if no bubbles are present. 
 
 
Fig. 5 MRI image using T1-w FSE in vitro. 
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Fig. 6 MRI image using T1-w FSE in vivo. 
 
IV. DISCUSSION 
Previous literature ([9-10]) demonstrated that lesions can be 
monitored with excellent contrast in rabbit brain (in vivo) 
using T1-w FSE with TR=500 ms. The lesions imaged in the 
previous studies and also in this study appeared bright with 
T1-w FSE, whereas brain tissue appeared gray. However in 
the previous studies only thermal lesions were shown. In this 
paper we have explored extensively the use of MRI to image 
both lesions created under thermal mechanisms and 
mechanisms that create bubbly lesions (cavitation or 
boiling).  
The signal intensity of the brain tissue is homogeneous 
using T1-w FSE, and therefore the contrast with thermal 
lesions or with bubbly lesions is excellent.  
Both T1-w FSE and T2-w FSE were able to detect lesions. 
This advantage is attributed to the significant difference in 
signal intensity between the thermal or bubbly lesions and 
brain tissue. It was observed that bubbly lesions appear 
darker than thermal lesions. Bubbly lesions appear dark, due 
to the air spaces resulting from cavities. This paper 
demonstrates that non-degassed excised tissue is a good 
model for easily initiating cavitation. This model of 
cavitation might not be of any significant for clinical use 
since the cavitation threshold in live tissue is very different 
from the threshold in the in vitro tissue. However, this model 
of initiating cavitation is very useful for the purpose of 
studying the MRI appearance of bubbly lesions. Cavitation is 
initiated if a blood vessel (which might include trapped 
bubbles) is targeted.  
The length of the lesions measured parallel to the 
ultrasonic beam (i.e. deep in the brain) was much higher than 
the length in vitro, proving that the penetration in the in vitro 
brain is limited by reflection due to trapped bubbles in the 
blood vessels. 
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